2016 - Fellow of the American Association for the Advancement of Science (AAAS)
His primary areas of investigation include Pathology, Molecular biology, Cancer research, Comparative genomic hybridization and Carcinogenesis. The Pathology study combines topics in areas such as Esophagus, Stomach and Adenocarcinoma. The study incorporates disciplines such as Glutathione peroxidase, Cancer, Gene expression profiling and Apoptosis, Biochemistry in addition to Molecular biology.
His Cancer research research is multidisciplinary, incorporating perspectives in Aurora kinase, Protein kinase B, Small interfering RNA, MNDA and Regulation of gene expression. His Comparative genomic hybridization research incorporates elements of Tumor progression and DNA. His research in the fields of Tumor suppressor gene overlaps with other disciplines such as Tyrosine kinase 2.
His primary areas of study are Cancer research, Molecular biology, Cancer, Carcinogenesis and Pathology. His Cancer research research includes themes of Aurora Kinase A, Helicobacter pylori, Cancer cell and Apoptosis, STAT3. DNA and Gene duplication is closely connected to Comparative genomic hybridization in his research, which is encompassed under the umbrella topic of Molecular biology.
In his research, Epigenetics is intimately related to DNA methylation, which falls under the overarching field of Cancer. His Carcinogenesis study incorporates themes from Inflammation, Immunology, Dysplasia, Gastric mucosa and Regulation of gene expression. Many of his studies involve connections with topics such as Esophagus and Pathology.
The scientist’s investigation covers issues in Cancer research, Carcinogenesis, Cancer, Helicobacter pylori and Oxidative stress. Wael El-Rifai interconnects Cancer cell, Esophageal adenocarcinoma, Metastasis, STAT3 and Gene silencing in the investigation of issues within Cancer research. His Esophageal adenocarcinoma study combines topics in areas such as Molecular biology and Wee1.
Many of his studies on Carcinogenesis apply to Radiation therapy as well. His Cancer research includes elements of Stomach, microRNA, MicroRNA sequencing and Real-time polymerase chain reaction. His studies in Oxidative stress integrate themes in fields like Cell culture, Gene knockdown, DNA, DNA damage and GERD.
Wael El-Rifai mainly focuses on Cancer research, Carcinogenesis, Cancer, Helicobacter pylori and Cancer cell. He combines subjects such as Oxidative stress, Apoptosis, STAT3, microRNA and Gene silencing with his study of Cancer research. His research integrates issues of Esophagus, In vivo, Gene knockdown and Cisplatin in his study of Oxidative stress.
His research investigates the connection between Gene silencing and topics such as CpG site that intersect with issues in Aurora Kinase A. The Cancer study combines topics in areas such as RNA, Stomach, Real-time polymerase chain reaction and Disease. His Helicobacter pylori study integrates concerns from other disciplines, such as PI3K/AKT/mTOR pathway and Ubiquitin ligase.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review.
Markku Miettinen;Wa'el El-Rifai;Wa'el El-Rifai;Leslie H L Sobin;Leslie H L Sobin;Jerzy Lasota;Jerzy Lasota.
Human Pathology (2002)
Clinical management of gastrointestinal stromal tumors : before and after STI-571
Ronald P. Dematteo;Michael C. Heinrich;Wa'el M. El-Rifai;George Demetri.
Human Pathology (2002)
DNA copy number amplifications in human neoplasms : Review of comparative genomic hybridization studies
S. Knuutila;A.-M. Björkqvist;K. Autio;M. Tarkkanen.
American Journal of Pathology (1998)
DNA Copy Number Losses in Human Neoplasms
Sakari Knuutila;Yan Aalto;Kirsi Autio;Anna Maria Björkqvist.
American Journal of Pathology (1999)
Gastric Cancers Overexpress S100A Calcium-binding Proteins
Wa'el El-Rifai;Christopher A. Moskaluk;Mohammad Khalouck Abdrabbo;Jeffery Harper.
Cancer Research (2002)
Aurora Kinase Inhibitors - Rising Stars in Cancer Therapeutics?
Altaf A. Dar;Laura W. Goff;Shahana Majid;Jordan Berlin.
Molecular Cancer Therapeutics (2010)
DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance.
Wa’el El-Rifai;Maarit Sarlomo-Rikala;Leif C. Andersson;Sakari Knuutila.
Cancer Research (2000)
Targets of Gene Amplification and Overexpression at 17q in Gastric Cancer
Asta Varis;Maija Wolf;Maija Wolf;Outi Monni;Marja Leena Vakkari.
Cancer Research (2002)
DNA hypermethylation regulates the expression of members of the Mu-class Glutathione-S-Transferases and Glutathione Peroxidases in Barrett's adenocarcinoma
DunFa Peng;Mohammad H Razvi;Heidi Chen;Kay Washington.
Gut (2009)
DNA Copy Number Losses in Chromosome 14: An Early Change in Gastrointestinal Stromal Tumors
Wa'el El-Rifai;Maarit Sarlomo-Rikala;Markku Miettinen;Sakari Knuutila.
Cancer Research (1996)
Gastroenterology
(Impact Factor: 33.883)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Helsinki
Vanderbilt University Medical Center
Vanderbilt University Medical Center
National University of La Plata
Vanderbilt University Medical Center
University of Virginia
University of Helsinki
National Cancer Institute
Vanderbilt University Medical Center
University of Helsinki
National Taiwan University
Princeton University
Chinese University of Hong Kong, Shenzhen
Sharif University of Technology
University of Göttingen
University of South Carolina
Wageningen University & Research
University of California, Irvine
University of Illinois at Urbana-Champaign
Swansea University
Florey Institute of Neuroscience and Mental Health
Leipzig University
Washington University in St. Louis
University of Pisa
University of California, San Diego
University of California, San Francisco